The global CAR T-cell therapy market is witnessing exponential growth, driven by increasing occurrence of cancer and supportive regulatory policies. Key players in the market are engaging in development to expand their product portfolio and address the growing requirement for effective cancer treatments. Moreover, advancements in CAR T-cell therap